GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Smith & Nephew Snats, Inc. (SNN) [hlAlert]

Rating:
Buy SNN
up 79.68 %

Smith & Nephew Snats, Inc. (SNN) upgraded to Buy by UBS

Posted on: Monday,  Feb 8, 2010  8:25 AM ET by UBS

UBS rated Buy Smith & Nephew Snats, Inc. (NYSE: SNN) on 02/08/2010, when the stock price was $19.74.
Since then, Smith & Nephew Snats, Inc. has gained 79.69% as of 12/07/2015's recent price of $35.47.
If you would have followed this UBS's recommendation on SNN, you would have gained 79.68% of your investment in 2128 days.

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/8/2010 8:25 AM Buy
None
19.74
as of 12/31/2010
1 Week up  8.29 %
1 Month up  23.45 %
3 Months up  23.70 %
1 YTD up  13.79 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/7/2009 8:25 AM Hold
None
17.09
6/18/2008 8:25 AM Buy
None
23.11

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy